STTEPP: Safety, Tolerability and Dose Limiting Toxicity of Lacosamide in Patients With Painful Chronic Pancreatitis
STTEPP: Safety, Tolerability and Dose Limiting Toxicity of Lacosamide in Patients With Painful Chronic Pancreatitis
Active, not recruiting · NCT05603702 · Registry updated 2026-06-03Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| STTEPP: Safety, Tolerability and Dose Limiting Toxicity of Lacosamide in Patients With Painful Chronic Pancreatitis | Chemically-Induced Disorders, Chronic Disease, Chronic Pain, Digestive System Diseases, Disease Attributes, Hyperalgesia, Narcotic-Related Disorders, Neurologic Manifestations, Opioid Use Disorder, Pain, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, Somatosensory Disorders, chronic pain syndrome, chronic pancreatitis, nervous system disorder, opiate dependence, pancreas disorder, pancreatitis, psychiatric disorder, substance-related disorder | Active, not recruiting | Phase 1 | 2026-06-03 | NCT05603702 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Indiana University | 297 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 617 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Indiana University | Indianapolis | United States | 160 |
| Mayo Clinic | Rochester | United States | 664 |
| Ohio State University | Columbus | United States | 169 |
| Stanford University | Stanford | United States | 213 |
| University of Pittsburgh Medical Center | Pittsburgh | United States | 127 |